Amgen will present the results from three Phase 2 studies of AMG 145 at the American Heart Association (AHA) Scientific Sessions 2013, taking place in Dallas November 16-20, 2013.
If you are at AHA, stop by Amgen's booth #720 to learn more.
Follow Amgen on Twitter at http://twitter.com/amgen to receive news updates during AHA.